Back to Blog

Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics

Simon Smith

On this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Leila Pirhaji, founder and CEO of ReviveMed. ReviveMed uses artificial intelligence to unlock the therapeutic potential of metabolomics. Before learning about ReviveMed, I knew little about metabolomics. Leila is an articulate and enthusiastic teacher, and her passion is infectious.

Listen now to learn about metabolomics, its potential for disease diagnosis and treatment, and how ReviveMed uses artificial intelligence to realize the opportunities:

Topics: Artificial Intelligence in Drug Discovery

Written by
Simon Smith

Never Miss a Blog Post!